Companies similar to BLACK DIAMOND THERAPEUTICS INC (BDTX)
Health Care · NASDAQ
BLACK DIAMOND THERAPEUTICS INC (BDTX)'s closest peers include ASTRAZENECA PLC (AZN), NOVARTIS AG (NVS), Lilly (Eli) (LLY) and Revolution Medicines (RVMD). This peer set is drawn from BDTX's enriched company profile and is informational only — not financial advice.
Similar companies
-
ASTRAZENECA PLCAZN
Leading global biopharmaceutical company developing targeted oncology, cardiovascular, and rare disease treatments backed by a strong R&D pipeline.
$169.34 (as of 2026-07-21) · market cap $195.3B
-
NOVARTIS AGNVS
Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
$153.87 (as of 2026-07-21) · market cap $228.2B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,175.41 (as of 2026-07-21) · market cap $1.08T
-
Revolution MedicinesRVMDHealth Care
A precision oncology biotech in clinical development stages, pursuing targeted cancer therapies with no approved products yet but backed by substantial capital.
$183.29 (as of 2026-07-21) · market cap $38.9B
Not quite? Describe exactly what you want →
Peers are drawn from BDTX's enriched profile (the same similarity signal the chat uses for "companies like BDTX"). See the full profile: BLACK DIAMOND THERAPEUTICS INC (BDTX).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.